WO2013175499A3 - Forme polymorphe du 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide - Google Patents

Forme polymorphe du 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide Download PDF

Info

Publication number
WO2013175499A3
WO2013175499A3 PCT/IN2013/000262 IN2013000262W WO2013175499A3 WO 2013175499 A3 WO2013175499 A3 WO 2013175499A3 IN 2013000262 W IN2013000262 W IN 2013000262W WO 2013175499 A3 WO2013175499 A3 WO 2013175499A3
Authority
WO
WIPO (PCT)
Prior art keywords
benzofuran
carboxamide
piperazin
indol
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2013/000262
Other languages
English (en)
Other versions
WO2013175499A2 (fr
Inventor
Shriprakash Dhar DWIVEDI
Ramesh Chandra SINGH
Rajendra Gokalbhai CHAVDA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zydus Lifesciences Ltd
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of WO2013175499A2 publication Critical patent/WO2013175499A2/fr
Anticipated expiration legal-status Critical
Publication of WO2013175499A3 publication Critical patent/WO2013175499A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention porte sur un procédé pour la préparation de 5-(4-[4-(5-cyano-1H-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide de formule (1) ou de son sel pharmaceutiquement acceptable ou de solvates ou d'hydrates de ceux-ci. En particulier, la présente invention porte sur un nouveau composé intermédiaire, 5-(pipérazin-1-yl 4-substitué)benzofurane-2-carboxamide de formule (X). La présente invention porte en outre sur une forme à l'état solide du 5-(4-[4-(5-cyano-1H-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide de formule (1) et sur un procédé pour sa préparation.
PCT/IN2013/000262 2012-04-20 2013-04-22 Forme polymorphe du 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide Ceased WO2013175499A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1260/MUM/2012 2012-04-20
IN1260MU2012 2012-04-20

Publications (2)

Publication Number Publication Date
WO2013175499A2 WO2013175499A2 (fr) 2013-11-28
WO2013175499A3 true WO2013175499A3 (fr) 2014-10-23

Family

ID=49036619

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2013/000262 Ceased WO2013175499A2 (fr) 2012-04-20 2013-04-22 Forme polymorphe du 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide

Country Status (1)

Country Link
WO (1) WO2013175499A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9382233B2 (en) 2012-06-13 2016-07-05 Apotex Inc. Forms of vilazodone and processes for the preparation thereof
CA2884676A1 (fr) 2012-09-12 2014-03-20 Apotex Pharmachem Inc. Procedes de preparation de 3-alkyl-indoles
WO2014061004A2 (fr) * 2012-10-19 2014-04-24 Ranbaxy Laboratories Limited Procédé pour la préparation de vilazodone ou de sel pharmaceutiquement acceptable de celui-ci
US20140179713A1 (en) * 2012-11-05 2014-06-26 Cadila Healthcare Limited Polymorphic form of 5-(4-[4-(5-cyano-1h-indol-3-yl) butyl] piperazin-1-yl) benzofuran-2-carboxamide and process for preparing thereof
CN104926804B (zh) * 2015-06-04 2019-01-25 天津渤海职业技术学院 一类具有抗肿瘤作用的化合物、其制备方法和用途
CN105541811A (zh) * 2016-01-08 2016-05-04 万特制药(海南)有限公司 一种抗抑郁药物维拉佐酮的精制方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738722A1 (fr) * 1995-04-20 1996-10-23 MERCK PATENT GmbH Dérivés d'acides 5-amino-benzofuran-2-carboxyliques
CN102267985A (zh) * 2011-06-15 2011-12-07 上海医药工业研究院 维拉佐酮或其盐酸盐的制备方法
WO2013114338A1 (fr) * 2012-02-01 2013-08-08 Ranbaxy Laboratories Limited Procédé pour la préparation de vilazodone ou de ses sels pharmaceutiquement acceptables

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738722A1 (fr) * 1995-04-20 1996-10-23 MERCK PATENT GmbH Dérivés d'acides 5-amino-benzofuran-2-carboxyliques
CN102267985A (zh) * 2011-06-15 2011-12-07 上海医药工业研究院 维拉佐酮或其盐酸盐的制备方法
WO2013114338A1 (fr) * 2012-02-01 2013-08-08 Ranbaxy Laboratories Limited Procédé pour la préparation de vilazodone ou de ses sels pharmaceutiquement acceptables

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HEINRICH T ET AL: "Synthesis and Structure-Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 47, no. 19, 1 January 2004 (2004-01-01), pages 4684 - 4692, XP002388367, ISSN: 0022-2623, DOI: 10.1021/JM040793Q *

Also Published As

Publication number Publication date
WO2013175499A2 (fr) 2013-11-28

Similar Documents

Publication Publication Date Title
WO2011153157A3 (fr) Inhibiteurs benzoquinolone de vmat2
WO2013098833A3 (fr) Procédés et intermédiaires destinés à la préparation de rivaroxaban
WO2011127290A3 (fr) Formes solides de l'acide 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yle) cyclopropane carboxamido)-3-méthylpyridin-2-yle) benzoïque
CA2826751C (fr) Procedes de synthese de quinoleines et compositions pharmaceutiques les incluant
PL3290414T3 (pl) Sposób otrzymywania n-[5-(3,5-difluorobenzylo)-1h-indazol-3-ilo]-4-(4-metylopiperazyn-1-ylo)-2-(tetrahydropiran-4-yloamino)benzamidu
WO2010105179A3 (fr) Inhibiteurs de bêta-sécrétase
WO2006007532A3 (fr) Composes heteroaryles substitues en 2
IN2014KN00948A (fr)
MY167791A (en) 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
WO2013175499A3 (fr) Forme polymorphe du 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]pipérazin-1-yl)benzofurane-2-carboxamide
MD20140136A2 (ro) Inhibitori ai virusului hepatic C
MY150778A (en) Fused heterocyclic compound
WO2015033357A3 (fr) Procédé amélioré de préparation de dérivés de pyrrole
HK1206021A1 (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
MY151211A (en) 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
WO2012101011A3 (fr) Nouveaux dérivés d'arylbenzocycloalkylamides
WO2010140765A3 (fr) Nouveau procédé de préparation de rosuvastatine, composés intermédiaires utiles pour préparer de la rosuvastatine, et procédé de préparation correspondant
WO2012042534A3 (fr) Procédés de préparation de r-sitagliptine et de ses intermédiaires
WO2010056644A8 (fr) 1-(arylsulfonyl)-4-(pipérazin-1-yl)-1h-benzimidazoles en tant que ligands de δ-hydroxytriptamine-6
NZ742952A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
AU2010243044A8 (en) Carbinol compound having heterocyclic linker
WO2011008666A3 (fr) Composés 3-phénoxyméthylpyrrolidines
WO2016135747A3 (fr) Processus de préparation d'un composé amorphe (1s)-1,5-anhvdro-1-[3- [[5- (4 fluorophényl)-2-thiényl]methvl]-4-méthylphényl]-d-glucitol et de ses formes polymorphes
WO2010077730A3 (fr) Inhibiteurs indanones de l'acétylcholinestérase
MX359399B (es) Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13753356

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13753356

Country of ref document: EP

Kind code of ref document: A2